Who owns Oramed Pharm?
- Ticker: ORMP
- CUSIP Number: 68403P203
Tip: Access positions for across all investors
Analyze quarterly positions in Oramed Pharm with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oramed Pharm stock
Who bought or sold Oramed Pharm this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 845k | $2.5M | -33% | Mar 2024 |
|
| Two Sigma Advisers | 284k | $655k | 71% | Dec 2023 |
|
| Bank of America Corporation | 271k | $627k | 1222% | Dec 2023 |
|
| Two Sigma Investments | 157k | $363k | 399% | Dec 2023 |
|
| Squarepoint Ops | 117k | $271k | 122% | Dec 2023 |
|
| Jane Street | 96k | $221k | 775% | Dec 2023 |
|
| D. E. Shaw & Co | 59k | $137k | 100% | Dec 2023 |
|
| Citadel Advisors | 44k | $102k | 109% | Dec 2023 |
|
| Jpmorgan Chase & Co | 29k | $66k | -37% | Dec 2023 |
|
| Pnc Financial Services | 26k | $61k | -4% | Dec 2023 |
|
| Assenagon Asset Management | 19k | $55k | 100% | Mar 2024 |
|
| Algert Coldiron Investors | 15k | $34k | 0% | Dec 2023 |
|
| Barclays | 13k | $30k | -28% | Dec 2023 |
|
| N.E.W. Advisory Services | 13k | $38k | 0% | Mar 2024 |
|
| Altshuler Shaham | 13k | $30k | 0% | Dec 2023 |
|
| Wealth Enhancement Advisory Services | 11k | $33k | -4% | Mar 2024 |
|
| Close Asset Management | 11k | $26k | 0% | Dec 2023 |
|
| Hrt Financial | 11k | $25k | 100% | Dec 2023 |
|
| Glass Jacobson Investment Advisors | 11k | $24k | -14% | Dec 2023 |
|
| Royal Bank of Canada | 9.2k | $21k | 75% | Dec 2023 |
|
| AJOVista | 8.4k | $19k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 8.4k | $19k | -57% | Dec 2023 |
|
| UBS Group | 5.1k | $12k | -18% | Dec 2023 |
|
| Huntington National Bank | 5.0k | $12k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 4.5k | $10k | 0% | Dec 2023 |
|
| LM Advisors | 2.5k | $5.8k | 100% | Dec 2023 |
|
| McIlrath & Eck | 2.0k | $4.6k | 0% | Dec 2023 |
|
| Rhumbline Advisers | 1.8k | $4.2k | 0% | Dec 2023 |
|
| IFP Advisors | 1.5k | $3.5k | -14% | Dec 2023 |
|
| City Holding | 1.1k | $3.1k | 0% | Mar 2024 |
|
| Proequities | 1.0k | $2.3M | 0% | Dec 2023 |
|
| Newbridge Financial Services Group | 657.00 | $1.5k | 0% | Dec 2023 |
|
| Federated Investors | 369.00 | $851.984100 | 202% | Dec 2023 |
|
| Tyler-Stone Wealth Management | 300.00 | $693.000000 | 0% | Dec 2023 |
|
| Beacon Capital Management | 219.00 | $572.006100 | 0% | Dec 2023 |
|
| Global Retirement Partners | 100.00 | $292.000000 | 0% | Mar 2024 |
|
| Brown Brothers Harriman & Co. | 8.00 | $18.000000 | 0% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 2.00 | $5.000000 | -85% | Dec 2023 |
|
Who sold out of Oramed Pharm?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Sep 2023 | 154k | $401k |
| GSA Capital Partners | Sep 2023 | 89k | $232k |
| Citigroup | Sep 2023 | 42k | $108k |
| Dimensional Fund Advisors | Sep 2023 | 27k | $71k |
| Virtu Financial | Sep 2023 | 17k | $45k |
| Bourgeon Capital Management | Dec 2023 | 5.6k | $13k |
| Simplex Trading | Sep 2023 | 2.5k | $6.0k |
| TD Waterhouse Canada | Sep 2023 | 1.0k | $2.6k |